Pyruvate dehydrogenase E2 deficiency: a potentially treatable cause of episodic dystonia
- PMID: 20022530
- DOI: 10.1016/j.ejpn.2009.11.001
Pyruvate dehydrogenase E2 deficiency: a potentially treatable cause of episodic dystonia
Abstract
The association of progressive episodic dystonia and learning disability with distinctive neuroimaging findings may lead to consideration of atypical Pantothenate Kinase Associated Neurodegeneration (PKAN) and investigations directed towards that diagnosis. Recent reports indicate that deficiency of dihydrolipoamide acetyltransferase, the E2 component of the pyruvate dehydrogenase complex, may present similarly, and that this disorder should also be considered in the differential diagnosis. We describe two sisters with early onset episodic dystonia and pyruvate dehydrogenase deficiency caused by defects in the E2 subunit. Both have neuroimaging features similar to previously described patients and have mutations in the DLAT gene. As this condition is potentially treatable with a ketogenic diet, the possibility of this diagnosis should be considered in similar cases.
Copyright (c) 2009 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Pyruvate dehydrogenase complex-E2 deficiency causes paroxysmal exercise-induced dyskinesia.Neurology. 2017 Nov 28;89(22):2297-2298. doi: 10.1212/WNL.0000000000004689. Epub 2017 Nov 1. Neurology. 2017. PMID: 29093066 Free PMC article. No abstract available.
-
Clinical and genetic spectrum of pyruvate dehydrogenase deficiency: dihydrolipoamide acetyltransferase (E2) deficiency.Ann Neurol. 2005 Aug;58(2):234-41. doi: 10.1002/ana.20550. Ann Neurol. 2005. PMID: 16049940
-
Spectrum of neurological and survival outcomes in pyruvate dehydrogenase complex (PDC) deficiency: lack of correlation with genotype.Mol Genet Metab. 2012 Nov;107(3):394-402. doi: 10.1016/j.ymgme.2012.09.001. Epub 2012 Sep 7. Mol Genet Metab. 2012. PMID: 23021068
-
Defects of pyruvate metabolism and the Krebs cycle.J Child Neurol. 2002 Dec;17 Suppl 3:3S26-33; discussion 3S33-4. J Child Neurol. 2002. PMID: 12597053 Review.
-
A novel mutation in the dihydrolipoamide dehydrogenase E3 subunit gene (DLD) resulting in an atypical form of alpha-ketoglutarate dehydrogenase deficiency.Hum Mutat. 2005 Mar;25(3):323-4. doi: 10.1002/humu.9319. Hum Mutat. 2005. PMID: 15712224 Review.
Cited by
-
Treatable Hyperkinetic Movement Disorders Not to Be Missed.Front Neurol. 2021 Dec 1;12:659805. doi: 10.3389/fneur.2021.659805. eCollection 2021. Front Neurol. 2021. PMID: 34925200 Free PMC article. Review.
-
Phenylbutyrate increases pyruvate dehydrogenase complex activity in cells harboring a variety of defects.Ann Clin Transl Neurol. 2014 Jul;1(7):462-70. doi: 10.1002/acn3.73. Epub 2014 Jun 19. Ann Clin Transl Neurol. 2014. PMID: 25356417 Free PMC article.
-
Pyruvate dehydrogenase complex-E2 deficiency causes paroxysmal exercise-induced dyskinesia.Neurology. 2017 Nov 28;89(22):2297-2298. doi: 10.1212/WNL.0000000000004689. Epub 2017 Nov 1. Neurology. 2017. PMID: 29093066 Free PMC article. No abstract available.
-
The spectrum of pyruvate oxidation defects in the diagnosis of mitochondrial disorders.J Inherit Metab Dis. 2015 May;38(3):391-403. doi: 10.1007/s10545-014-9787-3. Epub 2014 Dec 20. J Inherit Metab Dis. 2015. PMID: 25526709 Review.
-
The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.Mol Genet Metab. 2012 Jul;106(3):385-94. doi: 10.1016/j.ymgme.2012.03.017. Mol Genet Metab. 2012. PMID: 22896851 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials